Merck is charging $200,000 for the life-saving cancer drug Keytruda. They’re making a fortune off it. But it was developed using tax-payer dollars. That means the federal government has the little-known power to lower the price by taking Merck’s patent and giving it away.
Taxpayers Funded a Life-Saving Drug. Now It’s Unaffordable
